The launching ceremony of Qiankang Life Science International R&D Center and the commissioning ceremony of the new production base was held
On the morning of December 10, the launching ceremony of Qiankang Life Science International R&D Center and the commissioning ceremony of the new production base was held in Changsha Yuhua Economic Development Zone. At the event site, Hunan Qiankang Science and Technology signed a strategic cooperation framework agreement with some cooperative units such as the National Clinical Research Center for Geriatric Diseases (Huashan), the European Regional Sales Headquarters, the South Korea Regional Sales Headquarters, and Dian Diagnostic Technology Group.
Former leaders of relevant ministries and commissions, Luo Qiang, member of the party group and deputy director of the Municipal Science and Technology Bureau, Tan Liming, member of the party group and deputy director of the Municipal Health and Health Commission, Liu Suyue, secretary of the Yuhua District Party Committee, Huang Junqi, deputy secretary of the district party committee and head of the district people's **, Dai Bifeng, vice chairman of the district CPPCC and director of the District Science and Technology Bureau, attended the meeting, and Chen Haibo, secretary of the Party Working Committee of Yuhua Economic Development Zone, presided over the meeting.
Founded in 2014, Qiankang Technology is a Sino-foreign joint venture biotechnology focusing on the research of key technologies of Alzheimer's disease, which is a global medical difficulty, and is also a national high-tech enterprise, a governing unit of the China Alzheimer's Disease Prevention and Control Association, and a caring enterprise of the Red Cross. Before the launching ceremony, Professor Colin Masters, a global leader scientist in the field of Alzheimer's disease, a multi-time Nobel Prize nominee, the head of the Florey Institute of the University of Melbourne, the founder of AIBL, one of the world's largest dementia research cohorts, and one of the earliest discoverers of Alzheimer's disease early marker A, sent his blessings through **.
Qiankang Life Science International R&D Center provides overall solutions for the prevention, screening, diagnosis and treatment of Alzheimer's disease, with an area of nearly 2,000 square meters and is equipped with international high-end laboratory equipment. The center signed a strategic cooperation agreement with the National Clinical Research Center for Geriatric Diseases (Huashan) to carry out comprehensive cooperation in scientific research, scientific and technological innovation, achievement transformation, clinical verification and product promotion, give full play to their respective advantages, and jointly build a new system of deep integration of industry, university and research through multi-form and multi-level scientific and technological exchanges and cooperation, and jointly promote the comprehensive cooperation between enterprises and universities.
After the launch of the international R&D center, Qiankang Technology will open up a new track for high-quality development of the industry, focusing on the research and development of products such as leukocyte antigens, somatic cell gene testing, and macrophage diagnosis, so as to rapidly promote the transformation of scientific research achievements into productivity. At present, the urine formaldehyde detection kit, a dry chemical product for early screening of Alzheimer's disease, has entered the stage of achievement transformation and is expected to be launched in 2024.
Qiankang Life Science International R&D Center and new production base is the second phase of the Qiankang Science and Technology R&D and Production Base Project, with a number of 10,000-level clean workshops and 100,000-level clean workshops, and it is also planned to expand the primary antibody production line and build the first A antibody production line in the central region. "The construction of the new production base started in July this year, and we will be put into operation within half a year, and our production will be increased by six times in the future. The relevant person in charge of Qiankang Technology introduced.
With the signing of cooperation agreements with overseas sales companies, a number of leading enterprises of insurance companies, and some domestic distributors, the strategic layout of Qiankang Technology's global market has begun to take shape. It is reported that in 2024, the domestic market of Qiankang Technology will be dominated by hospital clinical departments, community central hospitals, OTC pharmacies, physical examination centers, bancassurance channels and cooperation with local ** to carry out Alzheimer's disease community screening, while overseas markets will focus on the European Union, Southeast Asia, the Middle East and other places.
After the launching ceremony, all the staff also visited the exhibition hall, laboratory, production and R&D workshop of Qiankang Science and Technology, and took a group photo.
Qiankang Technology is a key enterprise in the intelligent biomedical (pharmaceutical) industry in Yuhua Economic Development Zone. The launch of the Qiankang Life Science International R&D Center is another achievement of Yuhua Economic and Technological Development Zone to promote the stationing of key scientific research carrier platforms, and to integrate the innovation chain, connect the talent chain and string up the industrial chain with the platform. For a long time, Yuhua Economic and Technological Development Zone has focused on the main innovation of enterprises, and up to now, there are 41 national and provincial specialized and new "little giant" enterprises, 64 intelligent manufacturing demonstration enterprises, 220 high-tech enterprises, 1 national manufacturing individual champion enterprise, and 3 provincial manufacturing individual champion enterprises. In the future, Yuhua Economic and Technological Development Zone will continue to be based on the industrial chain and create the best environment, so that more innovative resource elements such as scientific and technological innovation platforms and scientific and technological talents will flock to the park and agglomeration parks, form a centripetal force of scientific and technological innovation, and help Changsha build a global R&D center city.
*: Yuhua District Rong ** Center.
Reporter: Chen Jing Correspondent: Liu Siya.
Love at first sight in Yuhua